These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 33132902)

  • 21. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
    Mulligan VK; Chakrabartty A
    Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal models for prion-like diseases.
    Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
    Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.
    Carver JA; Ecroyd H; Truscott RJW; Thorn DC; Holt C
    Acc Chem Res; 2018 Mar; 51(3):745-752. PubMed ID: 29442498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein Misfolding Diseases and Therapeutic Approaches.
    Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.
    Grad LI; Fernando SM; Cashman NR
    Neurobiol Dis; 2015 May; 77():257-65. PubMed ID: 25701498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.
    Sulistio YA; Heese K
    Mol Neurobiol; 2016 Mar; 53(2):905-931. PubMed ID: 25561438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation by Different Types of Chaperones of Amyloid Transformation of Proteins Involved in the Development of Neurodegenerative Diseases.
    Muronetz VI; Kudryavtseva SS; Leisi EV; Kurochkina LP; Barinova KV; Schmalhausen EV
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion-Like Mechanisms in Parkinson's Disease.
    Ma J; Gao J; Wang J; Xie A
    Front Neurosci; 2019; 13():552. PubMed ID: 31275093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.
    Nagai Y; Fujikake N; Popiel HA; Wada K
    Curr Pharm Biotechnol; 2010 Feb; 11(2):188-97. PubMed ID: 20166962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity.
    Mannini B; Chiti F
    Front Mol Neurosci; 2017; 10():98. PubMed ID: 28424588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIM family proteins: roles in proteostasis and neurodegenerative diseases.
    Zhu Y; Afolabi LO; Wan X; Shim JS; Chen L
    Open Biol; 2022 Aug; 12(8):220098. PubMed ID: 35946309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.
    Majd S; Power JH; Grantham HJ
    BMC Neurosci; 2015 Oct; 16():69. PubMed ID: 26499115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular Chaperones As Therapeutic Targets in ALS to Restore Protein Homeostasis and Improve Cellular Function.
    Kalmar B; Greensmith L
    Front Mol Neurosci; 2017; 10():251. PubMed ID: 28943839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Emerging Roles of Extracellular Chaperones in Complement Regulation.
    Geraghty NJ; Satapathy S; Wilson MR
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.
    Yoshida S; Hasegawa T
    Neurochem Int; 2022 May; 155():105307. PubMed ID: 35181393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.